Transcutaneous Electrical Acupoint Stimulation for Opioid Consumption After Gastrointestinal Laparoscopic Surgery

Transcutaneous Electrical Acupoint Stimulation Clinical Trial

Official title: Effect of Whole-process Transcutaneous Electrical Acupoint Stimulation on Opioid Consumption After Gastrointestinal Laparoscopic Surgery: a Prospective, Randomised, Blinded, Placebo-controlled Study

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to evaluate the effect of whole-process transcutaneous electrical acupoint stimulation on opioid consumption after gastrointestinal laparoscopic surgery. All subjects received conventional multimodal analgesia. On this basis, the experimental group received whole-process transcutaneous electrical acupoint stimulation, while the control group received corresponding false stimulation.

Clinical Trial Description

Conventional multimodal analgesia protocols as follows：

1. Before the end of the operation, the surgical incision was infiltrated with 0.5% ropivacaine 10 mL locally.

2. Patients were transferred to the PACU and provided with patient-controlled intravenous analgesia with sufentanil for postoperative analgesia. The analgesia devices were set to a concentration of 1ug/mL, with a lockout interval of 15 minutes, and a 3 mL bolus，without an infusion dose. The pump was withdrawn 72h after surgery.

3. Flurbiprofen: 50mg per dose intravenously twice a day for postoperative three days. ;

Related Conditions & MeSH terms

• Transcutaneous Electrical Acupoint Stimulation

• NCT number: NCT06024200
• Study type: Interventional
• Source: Nanfang Hospital, Southern Medical University
• Contact: Guoxin Li, M.D.,Ph.D.
• Phone: +86 13802771450
• Email: gzliguoxin@163.com
• Status: Recruiting
• Phase: N/A
• Start date: June 2, 2023
• Completion date: January 30, 2024